146 related articles for article (PubMed ID: 20430817)
1. Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant.
Panepinto JC; Misener AL; Oliver BG; Hu G; Park YD; Shin S; White TC; Williamson PR
Microbiology (Reading); 2010 Aug; 156(Pt 8):2558-2565. PubMed ID: 20430817
[TBL] [Abstract][Full Text] [Related]
2. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs.
Kim J; Cho YJ; Do E; Choi J; Hu G; Cadieux B; Chun J; Lee Y; Kronstad JW; Jung WH
Fungal Genet Biol; 2012 Nov; 49(11):955-66. PubMed ID: 22975303
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole.
Posteraro B; Sanguinetti M; Sanglard D; La Sorda M; Boccia S; Romano L; Morace G; Fadda G
Mol Microbiol; 2003 Jan; 47(2):357-71. PubMed ID: 12519188
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
Paul S; Doering TL; Moye-Rowley WS
Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
[TBL] [Abstract][Full Text] [Related]
5. Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
Chang M; Sionov E; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378705
[No Abstract] [Full Text] [Related]
6. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.
Sanguinetti M; Posteraro B; La Sorda M; Torelli R; Fiori B; Santangelo R; Delogu G; Fadda G
Infect Immun; 2006 Feb; 74(2):1352-9. PubMed ID: 16428784
[TBL] [Abstract][Full Text] [Related]
7. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
8. Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Ghaffar M; Orr C; Webb G
PLoS One; 2019; 14(12):e0225701. PubMed ID: 31800598
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
[TBL] [Abstract][Full Text] [Related]
10. Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.
Xu J; Onyewu C; Yoell HJ; Ali RY; Vilgalys RJ; Mitchell TG
Antimicrob Agents Chemother; 2001 Feb; 45(2):420-7. PubMed ID: 11158735
[TBL] [Abstract][Full Text] [Related]
11. The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii.
Lockhart SR; Fothergill AW; Iqbal N; Bolden CB; Grossman NT; Garvey EP; Brand SR; Hoekstra WJ; Schotzinger RJ; Ottinger E; Patterson TF; Wiederhold NP
Antimicrob Agents Chemother; 2016 Apr; 60(4):2528-31. PubMed ID: 26787697
[TBL] [Abstract][Full Text] [Related]
12. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment.
Sionov E; Chang YC; Kwon-Chung KJ
Antimicrob Agents Chemother; 2013 Oct; 57(10):5127-30. PubMed ID: 23836187
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner.
Semighini CP; Averette AF; Perfect JR; Heitman J
PLoS Pathog; 2011 Nov; 7(11):e1002364. PubMed ID: 22114551
[TBL] [Abstract][Full Text] [Related]
14. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
15. Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans.
Lee H; Khanal Lamichhane A; Garraffo HM; Kwon-Chung KJ; Chang YC
Mol Microbiol; 2012 Apr; 84(1):130-46. PubMed ID: 22339665
[TBL] [Abstract][Full Text] [Related]
16. Creation, characterization and utilization of Cryptococcus neoformans mutants sensitive to micafungin.
Toh-E A; Ohkusu M; Shimizu K; Yamaguchi M; Ishiwada N; Watanabe A; Kamei K
Curr Genet; 2017 Dec; 63(6):1093-1104. PubMed ID: 28560585
[TBL] [Abstract][Full Text] [Related]
17. Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans.
Dbouk NH; Covington MB; Nguyen K; Chandrasekaran S
BMC Microbiol; 2019 Nov; 19(1):243. PubMed ID: 31694529
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.
Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
FEMS Yeast Res; 2012 Nov; 12(7):748-54. PubMed ID: 22731401
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
